Rutaecarpine targets hERG channels and participates in regulating electrophysiological properties leading to ventricular arrhythmia

Ge Zhan, Fang Wang, Yunqi Ding, Xianghua Li, Yuexin Li, Zhengrong Zhao, Jiaxin Li, Yan Liu, Xin Zhao, Meng Yan, Baoxin LiJournal of Cellular and Molecular Medicine 2021 · DOI

TL;DR

This study investigates how Rutaecarpine (Rut), a component of traditional Chinese medicine, causes cardiac arrhythmias by inhibiting the hERG potassium channel. Rut directly binds to specific sites on the hERG channel, leading to acute current reduction and accelerated inactivation. Furthermore, it downregulates hERG expression long-term via the PI3K/Akt/Sp1 pathway, ultimately increasing the risk of life-threatening ventricular arrhythmias.

What Problem Does This Paper Address?

Acquired long-QT syndrome (acLQTs), often triggered by drugs or medical conditions, is a significant cause of sudden cardiac death due to ventricular arrhythmias (VA). A common mechanism underlying drug-induced acLQTs is the disruption of cardiac hERG channel function. Given that many traditional Chinese herbal medicines, particularly alkaloids, have been associated with arrhythmia risks, there's a critical need to understand how specific compounds within these medicines interact with cardiac ion channels. This paper addresses the specific problem of elucidating the mechanism by which Rutaecarpine (Rut), an alkaloid found in traditional Chinese medicine, exerts its cardiotoxic effects, focusing on its interaction with the hERG channel and its contribution to ventricular arrhythmias.

Methods

The researchers employed a multi-faceted approach combining in vitro and in vivo techniques:

  • Patch-clamp electrophysiology: This standard technique was used to directly measure hERG channel currents (I<sub>hERG</sub>) in hERG-HEK293 cells to assess Rut's acute inhibitory effects and its impact on channel kinetics (inactivation and recovery).
  • Western Blotting: Used to quantify protein levels, specifically examining the expression of mature and immature hERG channels, as well as key signaling proteins like Sp1, PI3K, and Akt, after Rut treatment.
  • Immunoprecipitation (IP): Employed to investigate the phosphorylation status of Sp1 (specifically Thr and Tyr phosphorylation) and to confirm interactions between Sp1 and other proteins.
  • Molecular Docking: A computational method used to predict the binding sites of Rut within the hERG channel and to understand the nature of these interactions.
  • Optical Mapping: A sophisticated technique used in isolated guinea pig hearts to visualize cardiac electrical activity in real-time. This allowed for the assessment of action potential duration (APD), conduction velocity (CV), and the dynamics of ventricular fibrillation (VF), including dominant frequency (DF) and phase singularities (PSs).
  • Programmed Electrical Stimulation: Used in guinea pig hearts to induce and study ventricular fibrillation (VF) and assess its inducibility and characteristics.
  • ECG Telemetry: Performed on live guinea pigs to measure QT and QTc intervals, providing an in vivo assessment of cardiac repolarization.
  • Cell Culture and Transfection: Standard methods for maintaining and manipulating hERG-expressing HEK293 cells.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Dual Mechanism of hERG Inhibition: Rut doesn't just acutely block hERG channels; it also has a long-term effect by reducing hERG protein expression. This dual action highlights a more complex cardiotoxic profile.
  • Specific Binding Sites: Rut's acute inhibition is not indiscriminate; it specifically targets and binds to the F656 and Y652 amino acid residues within the hERG channel. This precise interaction is crucial for its immediate effect.
  • PI3K/Akt/Sp1 Axis as a Regulator: The study uncovers a novel signaling pathway (PI3K/Akt/Sp1) that Rut manipulates to downregulate hERG expression. This pathway is critical for understanding the long-term effects and provides a potential therapeutic target.
  • Translational Relevance: The findings move beyond cell-based models to in vivo studies in guinea pigs, demonstrating that Rut's effects translate to prolonged QT intervals and increased susceptibility to life-threatening ventricular arrhythmias, directly linking the molecular mechanism to clinical risk.
  • Arrhythmia Dynamics: The paper goes beyond simply observing arrhythmias to analyzing their dynamics (DF and PSs), providing deeper insights into the mechanisms driving VF.

Key Results

  • Acute Inhibition: Rut (1 µM and 10 µM) significantly reduced hERG tail currents in a concentration-dependent manner, decreasing them to 22% and 51% of control, respectively. It also accelerated hERG channel inactivation.
  • Binding Site Identification: Molecular docking and experiments with mutant hERG channels (Y652A and F656V) confirmed that Rut binds to F656 and Y652 residues.
  • Drug Trapping: Rut exhibited a degree of trapping within hERG channels, with measured values of 10% and 19%.
  • Long-Term Effects: Incubation with Rut for 24 hours significantly reduced both mature (155 kDa) and immature (135 kDa) hERG protein levels, as well as hERG mRNA expression.
  • Signaling Pathway Modulation: Rut treatment led to decreased Thr/Tyr phosphorylation of Sp1 and reduced expression of Akt and PI3K.
  • In Vivo Arrhythmia: In guinea pigs, Rut administration (25 mg/kg/d for 2 weeks) significantly prolonged QT/QTc intervals and dramatically increased VF induction rates from 16.7% to 87.5%.
  • Electrophysiological Changes in Vivo: Rut prolonged APD<sub>50</sub> and APD<sub>90</sub>, slowed ventricular conduction, increased dominant frequency (DF) of VF, and increased the number of phase singularities (PSs). Early afterdepolarizations (EADs) were also observed to increase.

Limitations and Future Work

  • Cell-based vs. In Vivo: The authors acknowledge that cell-based models cannot fully replicate the complexity of pathological processes in a whole organism. The in vivo studies in guinea pigs help bridge this gap, but further validation in other animal models or human studies might be beneficial.
  • Specific Drug Interactions: While Rut's effects are detailed, the paper doesn't explore potential interactions of Rut with other drugs that might also affect hERG channels, which is a common clinical scenario.
  • Therapeutic Potential: The study focuses on the cardiotoxic mechanisms. Future work could explore whether modulating the PI3K/Akt/Sp1 pathway could mitigate Rut-induced cardiotoxicity or if Rut itself could be a starting point for developing safer analogs.
  • Hsp70 Interaction: The paper notes that Rut did not interfere with the transport of hERG channels via Hsp70, suggesting that the mechanism is primarily related to channel function and expression regulation, not protein trafficking. This is a clear finding but also implies that other potential trafficking-related mechanisms are not at play.

Summary updated

Abstract

Drug-mediated or medical condition-mediated disruption of hERG function accounts for the main cause of acquired long-QT syndrome (acLQTs), which predisposes affected individuals to ventricular arrhythmias (VA) and sudden death. Many Chinese herbal medicines, especially alkaloids, have risks of arrhythmia in clinical application. The characterized mechanisms behind this adverse effect are frequently associated with inhibition of cardiac hERG channels. The present study aimed to assess the potent effect of Rutaecarpine (Rut) on hERG channels. hERG-HEK293 cell was applied for evaluating the effect of Rut on hERG channels and the underlying mechanism. hERG current (I<sub>hERG</sub> ) was measured by patch-clamp technique. Protein levels were analysed by Western blot, and the phosphorylation of Sp1 was determined by immunoprecipitation. Optical mapping and programmed electrical stimulation were used to evaluate cardiac electrophysiological activities, such as APD, QT/QTc, occurrence of arrhythmia, phase singularities (PSs), and dominant frequency (DF). Our results demonstrated that Rut reduced the I<sub>hERG</sub> by binding to F656 and Y652 amino acid residues of hERG channel instantaneously, subsequently accelerating the channel inactivation, and being trapped in the channel. The level of hERG channels was reduced by incubating with Rut for 24 hours, and Sp1 in nucleus was inhibited simultaneously. Mechanismly, Rut reduced threonine (Thr)/ tyrosine (Tyr) phosphorylation of Sp1 through PI3K/Akt pathway to regulate hERG channels expression. Cell-based model unables to fully reveal the pathological process of arrhythmia. In vivo study, we found that Rut prolonged QT/QTc intervals and increased induction rate of ventricular fibrillation (VF) in guinea pig heart after being dosed Rut for 2 weeks. The critical reasons led to increased incidence of arrhythmias eventually were prolonged APD<sub>90</sub> and APD<sub>50</sub> and the increase of DF, numbers of PSs, incidence of early after-depolarizations (EADs). Collectively, the results of this study suggest that Rut could reduce the I<sub>hERG</sub> by binding to hERG channels through F656 and Y652 instantaneously. While, the PI3K/Akt/Sp1 axis may play an essential role in the regulation of hERG channels, from the perspective of the long-term effects of Rut (incubating for 24 hours). Importantly, the changes of electrophysiological properties by Rut were the main cause of VA.
BibTeX
@article{zhan2021rutaecarpine,
  author = {Ge Zhan and Fang Wang and Yunqi Ding and Xianghua Li and Yuexin Li and Zhengrong Zhao and Jiaxin Li and Yan Liu and Xin Zhao and Meng Yan and Baoxin Li},
  title = {{Rutaecarpine targets hERG channels and participates in regulating electrophysiological properties leading to ventricular arrhythmia}},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2021},
  doi = {10.1111/jcmm.16292},
}
Figure